Wird geladen...

Biomarkers in prostate cancer: what’s new?

PURPOSE OF REVIEW: This review is intended to provide an overview of the current state of biomarkers for prostate cancer (PCa), with a focus on biomarkers approved by the US Food and Drug Administration (FDA) as well as biomarkers available from Clinical Laboratory Improvement Amendment (CLIA)-certi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Sartori, David A., Chan, Daniel W.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2014
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4110681/
https://ncbi.nlm.nih.gov/pubmed/24626128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCO.0000000000000065
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!